Home | About us | Editorial Board | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionContact Us   |  Subscribe   |  Advertise   |  Login  Page layout
Wide layoutNarrow layoutFull screen layout
Lung India Official publication of Indian Chest Society  
  Users Online: 3632   Home Print this page  Email this page Small font size Default font size Increase font size
Year : 1989  |  Volume : 7  |  Issue : 2  |  Page : 79-83

A Study Of Short - Course Chemotherapy For Pulmonary Tuberculosis Under Programme (Field) Conditions In Pondicherry

Correspondence Address:
V. K Padmanabhan

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

A short-course regimen has been implemented in Pondicherry with the objective of obtaining information on its feasibility, acceptability, toxicity and efficacy under programme (field) conditions. A total of 1441 patients received a six month period short-course regimen of lsoniazid (300 mg), Rifampicin (450 mg) and Pyrazinamide (1.5 g) daily for two months initially followed by Rifampicin (600 mg) and lsoniazid (600 mg) twice a week for the next four months. Ninety-eight percent of the patients had either mild or moderate disease radiologically. Chemotherapy was completed by 68% of the patients. One of the patients had smear positivity at the end of chemotherapy; 81% showed radiographic improvement. Successful short-course chemotherapy is feasible under existing programme conditions

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded79    
    Comments [Add]    

Recommend this journal